These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Frovatriptan succinate, a 5-HT1B/1D receptor agonist for migraine. Balbisi EA Int J Clin Pract; 2004 Jul; 58(7):695-705. PubMed ID: 15311727 [TBL] [Abstract][Full Text] [Related]
8. The efficacy and tolerability of frovatriptan and dexketoprofen for the treatment of acute migraine attacks. Allais G; Rolando S; De Lorenzo C; Benedetto C Expert Rev Neurother; 2014 Aug; 14(8):867-77. PubMed ID: 25056381 [TBL] [Abstract][Full Text] [Related]
9. Factors associated with frovatriptan response in patients with migraine: A prospective, observational study. Seo JG; Park SP Cephalalgia; 2016 Apr; 36(5):493-8. PubMed ID: 26170008 [TBL] [Abstract][Full Text] [Related]
10. Clinical efficacy of frovatriptan: placebo-controlled studies. Ryan R; Géraud G; Goldstein J; Cady R; Keywood C Headache; 2002 Apr; 42 Suppl 2():S84-92. PubMed ID: 12028324 [TBL] [Abstract][Full Text] [Related]
11. Frovatriptan for acute treatment of migraine associated with menstruation: results from an open-label postmarketing surveillance study. Newman LC; Harper S; Jones BA; Campbell J J Womens Health (Larchmt); 2009 Aug; 18(8):1265-73. PubMed ID: 19627225 [TBL] [Abstract][Full Text] [Related]
12. A randomized trial of frovatriptan for the intermittent prevention of menstrual migraine. Silberstein SD; Elkind AH; Schreiber C; Keywood C Neurology; 2004 Jul; 63(2):261-9. PubMed ID: 15277618 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic evaluation of frovatriptan. Negro A; Lionetto L; Casolla B; Lala N; Simmaco M; Martelletti P Expert Opin Drug Metab Toxicol; 2011 Nov; 7(11):1449-58. PubMed ID: 21929465 [TBL] [Abstract][Full Text] [Related]
14. Treatment response and tolerability of frovatriptan in patients reporting short- or long-duration migraines at baseline. Kelman L; Harper SQ; Hu X; Campbell JC Curr Med Res Opin; 2010 Sep; 26(9):2097-104. PubMed ID: 20642390 [TBL] [Abstract][Full Text] [Related]
15. [Meta-analysis of triptan treatment in migraine]. Nakashima K; Takeshima T; Kowa H No To Shinkei; 2004 Sep; 56(9):747-52. PubMed ID: 15552863 [No Abstract] [Full Text] [Related]
17. Frovatriptan: pharmacological differences and clinical results. Rapoport AM Curr Med Res Opin; 2001; 17 Suppl 1():s68-70. PubMed ID: 12463282 [TBL] [Abstract][Full Text] [Related]
18. Efficacy of frovatriptan and other triptans in the treatment of acute migraine of normal weight and obese subjects: a review of randomized studies. Saracco MG; Allais G; Tullo V; Zava D; Pezzola D; Reggiardo G; Omboni S; Benedetto C; Bussone G; Aguggia M Neurol Sci; 2014 May; 35 Suppl 1():115-9. PubMed ID: 24867847 [TBL] [Abstract][Full Text] [Related]
19. The Migraine Intervention Score - a tool to improve efficacy of triptans in acute migraine therapy: the ALADIN study. Göbel H; Heinze A Int J Clin Pract; 2011 Aug; 65(8):879-86. PubMed ID: 21762313 [TBL] [Abstract][Full Text] [Related]
20. Oral naratriptan approved for migraine attacks. Am J Health Syst Pharm; 1998 Apr; 55(7):638. PubMed ID: 9558416 [No Abstract] [Full Text] [Related] [Next] [New Search]